WSO December 2023 – Issue 3 - 1214

1214
International Journal of Stroke 18(10)
Table 1. (Continued)
PD
N
Diabetes
Neuropsychiatric disease
EVT, n (%)
Living location, n (%)
Assisted living Facility
Home/local Community
Nursing home
Rehabilitation facility
Retirement center
Skilled nursing Facility
Unknown/missing
Average care hours per week, median (IQR)
Time (min) from LKW to tPA bolus, median (IQR)
Time (min) from ED arrival to tPA bolus, median (IQR)
Time (min) from ED arrival to EVT, median (IQR)
Site, n (%)
Houston
Colorado
Indianapolis
Memphis
New York City
Burlingame
Los Angeles
254
89 (35.0)
59 (23.2)
43 (16.9)
26 (10.2)
201 (79.1)
8 (3.1)
0 (0)
3 (1.2)
15 (5.9)
1 (0.4)
3 (0, 32.5)
89 (66, 135)
39.0 (28.5, 53)
74.0 (50, 99)
197 (77.6)
19 (7.5)
5 (2.0)
15 (5.9)
3 (1.2)
8 (3.1)
7 (2.8)
ND
793
255 (32.2)
57 (7.2)
219 (27.6)
3 (0.4)
780 (98.4)
0 (0)
1 (0.1)
8 (1)
1 (0.1)
0 (0)
0 (0, 0)
85 (62, 124)
40.0 (29, 50)
62.5 (44.3, 89)
610 (76.9)
81 (10.2)
8 (1.0)
39 (4.9)
25 (3.2)
14 (1.8)
16 (2.0)
mRS, modified Rankin Scale; uw-mRS, utility-weighted modified Rankin Scale; PD, pre-existing disability; ND, no pre-existing disability; EVT,
endovascular therapy; LKW, last known well; ED, emergency department; IQR, interquartile range; tPA, tissue plasminogen activator; NIHSS,
National Institutes of Health Stroke Scale.
<0.001
0.05
0.85
0.19
0.17
p-Value
0.44
<0.001
<0.001
<0.001
The percentage of stroke mimics among tPA-eligible
patients in the PD versus ND groups was similar (10% vs.
9%). Seizures were the cause of mimics more often in the
PD group (46% vs. 17% in ND) and migraine in ND
patients (23% vs. 4% in PD).
Fewer PD patients were discharged home (41%) compared
to ND patients (70%). In the PD sub-groups, discharge
to home occurred in 50% of patients with baseline
mRS of 2, 42% of those with baseline mRS of 3, and only
23% of patients with a baseline mRS of 4-5 (Supplemental
International Journal of Stroke, 18(10)
Table S2). The mean ± SD number of home days during the
1-year follow-up period for PD patients were 206 ± 166
versus 318 ± 110 for ND patients. Discharge to home and
home days for PD patients in the MSU versus EMS groups
were not different.
Results of the EuroQ-5D Questionnaire for PD and ND
patients are presented in Supplemental Table S3. Among
patients with PD, 42-52% had moderate to extreme challenges
with mobility, self-care, and usual activities at 1 year,
versus 10-12% of ND patients. Twice as many PD patients

WSO December 2023 – Issue 3

Table of Contents for the Digital Edition of WSO December 2023 – Issue 3

Contents
WSO December 2023 – Issue 3 - Cover1
WSO December 2023 – Issue 3 - Cover2
WSO December 2023 – Issue 3 - 1143
WSO December 2023 – Issue 3 - Contents
WSO December 2023 – Issue 3 - 1145
WSO December 2023 – Issue 3 - 1146
WSO December 2023 – Issue 3 - 1147
WSO December 2023 – Issue 3 - 1148
WSO December 2023 – Issue 3 - 1149
WSO December 2023 – Issue 3 - 1150
WSO December 2023 – Issue 3 - 1151
WSO December 2023 – Issue 3 - 1152
WSO December 2023 – Issue 3 - 1153
WSO December 2023 – Issue 3 - 1154
WSO December 2023 – Issue 3 - 1155
WSO December 2023 – Issue 3 - 1156
WSO December 2023 – Issue 3 - 1157
WSO December 2023 – Issue 3 - 1158
WSO December 2023 – Issue 3 - 1159
WSO December 2023 – Issue 3 - 1160
WSO December 2023 – Issue 3 - 1161
WSO December 2023 – Issue 3 - 1162
WSO December 2023 – Issue 3 - 1163
WSO December 2023 – Issue 3 - 1164
WSO December 2023 – Issue 3 - 1165
WSO December 2023 – Issue 3 - 1166
WSO December 2023 – Issue 3 - 1167
WSO December 2023 – Issue 3 - 1168
WSO December 2023 – Issue 3 - 1169
WSO December 2023 – Issue 3 - 1170
WSO December 2023 – Issue 3 - 1171
WSO December 2023 – Issue 3 - 1172
WSO December 2023 – Issue 3 - 1173
WSO December 2023 – Issue 3 - 1174
WSO December 2023 – Issue 3 - 1175
WSO December 2023 – Issue 3 - 1176
WSO December 2023 – Issue 3 - 1177
WSO December 2023 – Issue 3 - 1178
WSO December 2023 – Issue 3 - 1179
WSO December 2023 – Issue 3 - 1180
WSO December 2023 – Issue 3 - 1181
WSO December 2023 – Issue 3 - 1182
WSO December 2023 – Issue 3 - 1183
WSO December 2023 – Issue 3 - 1184
WSO December 2023 – Issue 3 - 1185
WSO December 2023 – Issue 3 - 1186
WSO December 2023 – Issue 3 - 1187
WSO December 2023 – Issue 3 - 1188
WSO December 2023 – Issue 3 - 1189
WSO December 2023 – Issue 3 - 1190
WSO December 2023 – Issue 3 - 1191
WSO December 2023 – Issue 3 - 1192
WSO December 2023 – Issue 3 - 1193
WSO December 2023 – Issue 3 - 1194
WSO December 2023 – Issue 3 - 1195
WSO December 2023 – Issue 3 - 1196
WSO December 2023 – Issue 3 - 1197
WSO December 2023 – Issue 3 - 1198
WSO December 2023 – Issue 3 - 1199
WSO December 2023 – Issue 3 - 1200
WSO December 2023 – Issue 3 - 1201
WSO December 2023 – Issue 3 - 1202
WSO December 2023 – Issue 3 - 1203
WSO December 2023 – Issue 3 - 1204
WSO December 2023 – Issue 3 - 1205
WSO December 2023 – Issue 3 - 1206
WSO December 2023 – Issue 3 - 1207
WSO December 2023 – Issue 3 - 1208
WSO December 2023 – Issue 3 - 1209
WSO December 2023 – Issue 3 - 1210
WSO December 2023 – Issue 3 - 1211
WSO December 2023 – Issue 3 - 1212
WSO December 2023 – Issue 3 - 1213
WSO December 2023 – Issue 3 - 1214
WSO December 2023 – Issue 3 - 1215
WSO December 2023 – Issue 3 - 1216
WSO December 2023 – Issue 3 - 1217
WSO December 2023 – Issue 3 - 1218
WSO December 2023 – Issue 3 - 1219
WSO December 2023 – Issue 3 - 1220
WSO December 2023 – Issue 3 - 1221
WSO December 2023 – Issue 3 - 1222
WSO December 2023 – Issue 3 - 1223
WSO December 2023 – Issue 3 - 1224
WSO December 2023 – Issue 3 - 1225
WSO December 2023 – Issue 3 - 1226
WSO December 2023 – Issue 3 - 1227
WSO December 2023 – Issue 3 - 1228
WSO December 2023 – Issue 3 - 1229
WSO December 2023 – Issue 3 - 1230
WSO December 2023 – Issue 3 - 1231
WSO December 2023 – Issue 3 - 1232
WSO December 2023 – Issue 3 - 1233
WSO December 2023 – Issue 3 - 1234
WSO December 2023 – Issue 3 - 1235
WSO December 2023 – Issue 3 - 1236
WSO December 2023 – Issue 3 - 1237
WSO December 2023 – Issue 3 - 1238
WSO December 2023 – Issue 3 - 1239
WSO December 2023 – Issue 3 - 1240
WSO December 2023 – Issue 3 - 1241
WSO December 2023 – Issue 3 - 1242
WSO December 2023 – Issue 3 - 1243
WSO December 2023 – Issue 3 - 1244
WSO December 2023 – Issue 3 - 1245
WSO December 2023 – Issue 3 - 1246
WSO December 2023 – Issue 3 - 1247
WSO December 2023 – Issue 3 - 1248
WSO December 2023 – Issue 3 - 1249
WSO December 2023 – Issue 3 - 1250
WSO December 2023 – Issue 3 - 1251
WSO December 2023 – Issue 3 - 1252
WSO December 2023 – Issue 3 - 1253
WSO December 2023 – Issue 3 - 1254
WSO December 2023 – Issue 3 - 1255
WSO December 2023 – Issue 3 - 1256
WSO December 2023 – Issue 3 - 1257
WSO December 2023 – Issue 3 - 1258
WSO December 2023 – Issue 3 - 1259
WSO December 2023 – Issue 3 - 1260
WSO December 2023 – Issue 3 - Cover3
WSO December 2023 – Issue 3 - Cover4
https://europe.nxtbook.com/nxteu/sageuk/wso_202404
https://europe.nxtbook.com/nxteu/sageuk/ukstrokeforum_202402_supp
https://europe.nxtbook.com/nxteu/sageuk/wso_202403
https://europe.nxtbook.com/nxteu/sageuk/wso_202402
https://europe.nxtbook.com/nxteu/sageuk/wso_202401
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_US_UKOnly
https://europe.nxtbook.com/nxteu/sageuk/wso_2023123_ROW
https://europe.nxtbook.com/nxteu/sageuk/wso_2023101
https://europe.nxtbook.com/nxteu/sageuk/wso_202308
https://europe.nxtbook.com/nxteu/sageuk/wso_202307
https://europe.nxtbook.com/nxteu/sageuk/wso_202306
https://europe.nxtbook.com/nxteu/sageuk/wso_202304
https://europe.nxtbook.com/nxteu/sageuk/wso_202303
https://europe.nxtbook.com/nxteu/sageuk/wso_202302
https://europe.nxtbook.com/nxteu/sageuk/wso_202301
https://www.nxtbookmedia.com